Recovery Housing For Drug Dependent Pregnant Women

Phase 2

Completed

• Conditions: Drug Addiction
• Interventions: Behavioral: RBT; Behavioral: usual care

• Registration Number: NCT00497302
• Lead Sponsor: Johns Hopkins University

Brief Summary

For the past several years our research program has developed and tested an intensive outpatient intervention that is based in social learning theory and employs abstinence contingent access to recovery housing as a routine aspect of an intensive day treatment counseling program. The present project proposes to extend this treatment intervention to the special population of pregnant drug using women enrolled at the Center for Addiction and Pregnancy (CAP). We will compare an enhanced treatment that includes abstinence contingent recovery house living plus intensive individual therapy, to standard care at the CAP program. Specific aims of the project are derived from testing a two-group design are described below:

1. To determine whether financially supported abstinence-contingent recovery house placement plus individual counseling in pregnant drug-dependent women improves prenatal outpatient treatment retention.

2. To determine whether financially supported abstinence-contingent recovery house placement plus individual counseling in pregnant drug-dependent women reduces prenatal drug use.

3. To determine whether financially supported abstinence-contingent recovery house placement plus individual counseling results in better maternal and infant clinical birth outcomes (e.g., birth weight, estimated gestational age (EGA) at delivery, medical complications).

Detailed Description

Not available

Study Timeline

• Study Start: 2004-11
• Study First Submitted: 2007-07-05
• Study First Submitted QC: 2007-07-05
• Study First Posted: 2007-07-06
• Primary Completion: 2008-06
• Study Completion: 2009-08
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-01
• Last Update Posted: 2013-03-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 128

Inclusion Criteria

• CAP enrolled
• Age 18 or older
• Evidence of use of opiate and/or cocaine use in the past 30 days
• Assigned to pharmacotherapy free modality
• CAP admission at an estimated gestational age (EGA) <34 weeks

Exclusion criteria:

• Endorses current suicidal ideation
• Any medical disorders requiring extended or future hospitalization
• Meet diagnostic criteria for current DSM-IV alcohol dependence
• Meet diagnostic criteria for a current DSM-IV Axis I thought disorder (i.e. schizophrenia)
• Demonstrate significant cognitive impairment that precludes them from completing the initial assessment battery

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	RBT	receives housing based on drug abstinence
2	usual care	Usual care treatment at the Center for Addiction and Pregnancy

Primary Outcome Measures

Name	Time	Method
Treatment retention, drug free urine samples at follow-up and delivery	treatment entry until 12 months post treatment entry

Secondary Outcome Measures

Name	Time	Method
prenatal care compliance, neonatal and birth outcomes	treatment entry until 12 months post treatment entry

Trial Locations

Locations (1)

Center for Addiction and Pregnancy Jhons Hopkins Bayview Medical Center; 🇺🇸 Baltimore, Maryland, United States